The DOI matches its Crossref record; 708 of the 714 references it cites were found in a registry or an index, and 6 are not checked yet.
2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
Open accessAbstract
Youth and adult participation in sports continues to increase, and athletes may be diagnosed with potentially arrhythmogenic cardiac conditions. This international multidisciplinary document is intended to guide electrophysiologists, sports cardiologists, and associated health care team members in the diagnosis, treatment, and management of arrhythmic conditions in the athlete with the goal of facilitating return to sport and avoiding the harm caused by restriction. Expert, disease-specific risk assessment in the context of athlete symptoms and diagnoses is emphasized throughout the document. After appropriate risk assessment, management of arrhythmias geared toward return to play when possible is addressed. Other topics include shared decision-making and emergency action planning. The goal of this document is to provide evidence-based recommendations impacting all areas in the care of athletes with arrhythmic conditions. Areas in need of further study are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is a strong association between AF and genes such as KCNA5, SCN5A and TTN, while genes like LMNA and KCNQ1 present a weaker association with AF [35,36,37,38].”
From Atrial Fibrillation in Elite Athletes: A Comprehensive Review of the Literature (2024) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Recent guidelines reflect this trend toward considering catheter ablation as a first-line option in symptomatic patients with AF, irrespective of athletic status, thus acknowledging the benefits of early ablation for symptomatic AF, particularly in patients who do not respond well to medical management or who prefer a non-pharmacological approach [38].”
From Atrial Fibrillation in Elite Athletes: A Comprehensive Review of the Literature (2024) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
Self-citation
Research works printed but not linked: 10
- Mitchell, 1985, 16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984, J Am Coll Cardiol, 6, 1186
- Link, 2015, Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology, Circulation, 132, e339
- Hansen, 2023, Toxicology Screening in Sports-Related Sudden Cardiac Death: A Multinational Observational Study, JACC Clin Electrophysiol
- Link, 2015, Circulation, 132, e334
- Ebert, 1992, Hemodynamic responses of high-fit runners during head-up tilt testing to syncope, Physiologist, 35, 237
- Ferrario, 1996, Cardiac adaptation to training: Is it the key to understand the high incidence of positive tilt test in athletes, Abstr) Pacing and Electrophys, 19, 578
- Frederick, 1995, Comparison of aerobic capacity, parasympathetic modulation, and orthostatic tolerance, Abstract. Clin Auton Res, 5, 334
- Maron, 2015, Circulation, 132, e273
- Elliott, 2022, An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial, JACC Clin Electrophysiol
- Kusumoto, 2019, Circulation, 140, e382
Cited by
Sorted by citations
Kim, J. H., Baggish, A. L., Levine, B. D., Ackerman, M. J., Day, S. M., Dineen, E. H., Guseh, J. S., Gerche, A. L., Lampert, R. J., Martinez, M. W., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.12.025 · Cited by 151
Self-citationKim, J. H., Baggish, A. L., Levine, B. D., Ackerman, M. J., Day, S. M., Dineen, E. H., Guseh, J. S., Gerche, A. L., Lampert, R. J., Martinez, M. W., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001297 · Cited by 83
Self-citationAthlete’s Heart Revisited: Historical, Clinical, and Molecular Perspectives
Hsieh, P. N., Shen, S., Chukwurah, M. I., Churchill, T. W., Stewart, K. M., Chung, E. H., Weiner, R. B., Li, H., & Guseh, J. S. (2025) · Circulation Research · doi:10.1161/circresaha.125.325638 · Cited by 47
Self-citationAtrial fibrillation in former world-class rowers: role of environmental and genetic factors
Flannery, D., Cánovas, R., Janssens, K., Mitchell, A. M., D’Ambrosio, P., Spencer, L. W., Rowe, S. J., Paratz, E. D., Claessen, G., Myrstad, M., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf369 · Cited by 26
Current management of hypertrophic cardiomyopathy
Sikand, N., Stendahl, J., Sen, S., Lampert, R., & Day, S. (2025) · BMJ · doi:10.1136/bmj-2023-077274 · Cited by 26
Self-citation
Metadata
- Authors
- Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., James, C. A., Kim, J. H., Krahn, A. D., La Gerche, A., Link, M. S., MacIntyre, C., Mont, L., Salerno, J. C., & Shah, M. J.
- Affiliations
- Yale University (US)
- Harvard University (US)
- Mayo Clinic (US)
- Kansas City Heart Rhythm Institute (US)
- University of Pennsylvania (US)
- University of Utah (US)
- The University of Sydney (AU)
- University of Washington (US)
- Johns Hopkins University (US)
- Emory University (US)
- University of British Columbia (CA)
- The University of Texas Southwestern Medical Center (US)
- Children's Hospital of Philadelphia (US)
- ORCID
- Venue
- Heart Rhythm
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 21
- Issue
- 10
- Pages
- e151-e252
- ISSN
- 1547-5271 (ISSN-L)
- OpenAlex
- W4397024284
- Cited by
- 167
- References
- 711
- Citations by year
- 2026: 83 · 2025: 66 · 2024: 18
- FWCI
- 50.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Heart Rhythm (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- athlete's heart, arrhythmogenic cardiomyopathy, sudden cardiac death in athletes, risk assessment, return to sport, shared decision-making, emergency action planning, sports cardiology, arrhythmia management
- MeSH terms
- Return to Sport, Arrhythmias, Cardiac, Humans, Sports Medicine, Death, Sudden, Cardiac, Risk Assessment, Consensus, Athletes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
